Surgeon and Creative Writer. Interest:Education and the World, Ex Associate Professor RG Kar Medical College

Joined March 2019
Samik Kumar Bandyopadhyay retweeted
HPB Journal Highlight 💫The October issue of HPB features the MESODELPHI study by Leite et al., establishing the first international consensus definition of the mesopancreas and a framework for future surgical practice and research.
5
5
659
Samik Kumar Bandyopadhyay retweeted
AI-generated 3D models of the liver, tumors, and blood vessels can help predict the complexity of liver resection before surgery. This approach may support more individualized surgical planning and referral to appropriate centers. ovid.com/10.1097/SLA.0000000…
2
36
1
84
5,305
Samik Kumar Bandyopadhyay retweeted
⏰ Deadline Approaching - E-AHPBA Scientific & Research Grants! There's still time to apply for funding for your HPB research! 🔬 Up to €1,000 per project 👥 Open to current E-AHPBA members 📅 Application deadline: 10 November 2026 Don't miss this opportunity to advance your research and contribute to the future of HPB surgery! Find out more and apply: eahpba.org/scientific-and-re… #EAHPBA #HPB #SurgicalResearch #ResearchFunding
2
4
604
Samik Kumar Bandyopadhyay retweeted
📢 Just a few days to go until our next E-AHPBA Grand Rounds Webinar! Join us this Thursday as we explore Hepatic Echinococcosis, featuring expert-led presentations followed by Q&A and discussion. 📅 Thursday 22 October 2026 🕕 18:00 CEST 💻 Free to attend | Open to all There's still time to register! 🔗 Secure your place: eahpba.org/education-and-tra… #EAHPBA #EAHPBAGrandRounds #HPBSurgery #HepaticEchinococcosis #SurgicalEducation
1
4
480
Samik Kumar Bandyopadhyay retweeted
⭐️HPB Journal Highlight🔬 The October issue of HPB explores the potential of histotripsy, an innovative non-thermal ultrasound technology. Kimura et al. share early findings from 414 patients with over 600 tumours treated
2
4
823
Samik Kumar Bandyopadhyay retweeted
Join us in the IHPBA Early Career Group Lounge for an open and important discussion on Work–Life Integration. 📅 Friday 30 October 2026 ⏰ 09.30–10:00 📍 ECG Lounge, Exhibition Hall ☕ Bring a coffee, share your experiences and join the conversation.
2
8
10
800
Samik Kumar Bandyopadhyay retweeted
How do BRAF and KRAS mutation status affect survival after cytoreductive surgery and HIPEC for CRC peritoneal metastaes? Find out in this month's #DCRJournal: bit.ly/4zBQRSw
1
4
8
1,190
Samik Kumar Bandyopadhyay retweeted
🔬 Take your laparoscopic liver surgery skills to the next level! Join us for the E-AHPBA Lap Liver Masterclass, delivered in partnership with BOWA Medical and Corza Medical. 📅 10-11 December 2026 📍 BOWA Medical UK, Devon 🎟️ Places are limited - register today! 🔗 Register now: eahpba.org/education-and-tra… #EAHPBA #LiverSurgery #LaparoscopicSurgery #SurgicalEducation
2
6
719
Samik Kumar Bandyopadhyay retweeted
NGS of ctDNA for Precision Medicine in Advanced Biliary Tract Cancers ClinicalCancerReseach doi.org/10.1158/1078-0432.CC… 🔎10,937 pts 👉90% feasible vs 50% tissue 👉TAT 8 vs 27 days 👉83% ESCAT-I concordance 👉ctDNA prognostic: mOS 27.7 vs 13.6 mo 🧐ctDNA can expand access, accelerate precision medicine @myESMO @EASLnews @ILCAnews
3
20
52
2,955
Samik Kumar Bandyopadhyay retweeted
1
5
1
29
2,125
Samik Kumar Bandyopadhyay retweeted
KRAS, once considered undruggable in cancer, has finally become actionable. Read this cutting-edge review. bmjoncology.bmj.com/content/…
5
9
384
Samik Kumar Bandyopadhyay retweeted
Looking forward to joining the International HPB Surgery School tonight🇹🇷 From Asian guidelines to evolving concepts of borderline resectable HCC, I’ll share our perspectives on the changing landscape of HCC surgery🥦 See you there! #HCC #LiverCancer #HPBSurgery @NuhNRahbari
2
20
1,300
Samik Kumar Bandyopadhyay retweeted
🧭 International consensus set standards for EUS-guided choledochoduodenostomy with LAMS 🔸Preferred over percutaneous drainage after failed ERCP 🔸CBD ≥15 mm preferred 🔸Oral intake within 24h after uncomplicated procedures 📖 #OpenAccess 👉 bit.ly/4jlz1OG
1
21
52
2,752
Samik Kumar Bandyopadhyay retweeted
🦠 Gut microbiome composition is associated with response to neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma patients New #GUTScience journal research by Halle-Smith et al. asks an important question: could the bacteria living in our gut be linked to how well pancreatic cancer responds to chemotherapy? The researchers found differences in the gut microbiome of patients who responded differently to neoadjuvant chemotherapy. Some of the differences involved bacterial genes linked to how medicines are processed. Why could this matter for clinicians and patients? 🩺 Pancreatic cancer can be difficult to treat, and patients can respond very differently to the same treatment. Understanding whether the gut microbiome is linked to treatment response could eventually help researchers develop better ways to predict — and potentially improve — how patients respond to therapy. It is still too early to use the microbiome to guide individual treatment, but these findings add to growing evidence that the microbes living in our gut could be relevant to cancer care. 📖 Read the paper: bit.ly/4f6XRzg #GUTScience #PancreaticCancer #CancerResearch #GutMicrobiome #Microbiome #Chemotherapy #PrecisionMedicine #TranslationalResearch @druppygill @Gut_BMJ @BMJOpen_Gastro @FrontGastro_BMJ
2
7
1
18
1,740
Samik Kumar Bandyopadhyay retweeted
It was great to contribute a lecture to International HPB Surgery School with Prof. Aroori. We discussed about “Management of Initially Unresectable Colorectal Liver Metastasis “ Contents will be available through International HPB School Thank you for Prof Bozkurt and Veysel
2
16
1,127
Samik Kumar Bandyopadhyay retweeted
📢 Last chance to register Join the IHPBA & HPB Journal webinar tomorrow, 24 September at 13:00 BST, for expert insights on publishing success in the HPB Journal. 🔗 You can register now here: tinyurl.com/3ruvtnkf
🤖 Made with AI
3
2
1,066